Practice Guidelines for the Management of Bacterial Meningitis
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
In this guideline, we will review our recommendations for the diagnosis and management of bacterial meningitis.Recommendation categories are shown in table 1.The guideline represents data published through May 2004.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parameters such as CSF protein level, glucose level, and white blood cell (WBC) count may be inconsistent in differentiating viral from bacterial infections and nonspecific to provide treatment direction [9].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [9]
In the citing paper
“The sensitivity of CSF Gram stain is 60% to 80% in patients without antibiotic pretreatment and decreases by 20% with antibiotic pretreatment [9].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [9]
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Red Book: 2024–2027 Report of the Committee on Infectious Diseases
Committee on Infectious Diseases, A. A. O. P. (2024) · doi:10.1542/9781610027359 · Cited by 1,548
Principles and Practice of Infectious Diseases
Larson, H. E. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.9.907-a · Cited by 1,276
Dexamethasone in Adults with Bacterial Meningitis
de Gans, J., & van de Beek, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021334 · Cited by 1,205
Dexamethasone Therapy for Bacterial Meningitis
Lebel, M. H., Freij, B. J., Syrogiannopoulos, G. A., Chrane, D. F., Hoyt, M. J., Stewart, S. M., Kennard, B. D., Olsen, K. D., & McCracken, G. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191502 · Cited by 606
Infections of the Central Nervous System
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-415_1 · Cited by 592
Self-citationOdio, C. M., Faingezicht, I., Paris, M., Nassar, M., Baltodano, A., Rogers, J., Sáez-Llorens, X., Olsen, K. D., & McCragken, G. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242201 · Cited by 501 · cited 1×
“There have been 15 published trials on the use of adjunctive dexamethasone in infants and children with bacterial meningitis [49–63].”
Aronin, S. I., Peduzzi, P., & Quagliarello, V. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_1-199812010-00004 · Cited by 486 · cited 4×
“In the recent study in adults cited above [71], only 72% of 108 CSF pneumococcal isolates were submitted for in vitro susceptibility testing, and all were susceptible to penicillin, an unusual finding in the United States and in many areas of the world.”
InfluentialMylonakis, E., Hohmann, E. L., & Calderwood, S. B. (1998) · Medicine · doi:10.1097/00005792-199809000-00002 · Cited by 475 · cited 1×
“The likelihood of having a positive Gram stain result also depends on the specific bacterial pathogen causing meningitis [3, 10]: 90% of cases caused by Streptococcus pneumoniae, 86% of cases caused by Haemophilus influenzae, 75% of cases caused by Neisseria meningitidis, 50% of cases caused by gram-negative bacilli,…”
Current Clinical Topics in Infectious Diseases
(1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350150042013 · Cited by 471
Research works printed but not linked: 3
- American Academy of Pediatrics, 2003, Pneumococcal infections, 490
- Kaufman, 1997, Infections of cerebrospinal fluid shunts, 555
- Kaufman, 1997, Infections of cerebrospinal fluid shunts, 555
Cited by
Items 201–300 of 1,003
Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides
Kaye, D. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.007 · Cited by 71
Intracerebroventricular drug administration
Atkinson, A. J. (2017) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2017.25.3.117 · Cited by 70
Bøving, M. K., Pedersen, L. N., & Møller, J. K. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01966-08 · Cited by 69
“Since the early administration of antibiotics correlates with reduced rates of morbidity and mortality, it is of crucial importance to initiate relevant treatment as soon as possible (10, 11, 13, 19, 22).”
BackgroundBlassmann, U., Roehr, A. C., Frey, O. R., Vetter‐Kerkhoff, C., Thon, N., Hope, W. W., Briegel, J., & Huge, V. (2016) · Critical Care · doi:10.1186/s13054-016-1523-y · Cited by 80
“Meropenem plus vancomycin is a frequently used antimicrobial combination for management of IVC-related infections because of its broad spectrum of antimicrobial activity [2, 4].”
BackgroundManagement of infections associated with neurosurgical implanted devices
Conen, A., Fux, C. A., Vajkoczy, P., & Trampuž, A. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1267563 · Cited by 69
Karageorgopoulos, D. E., Valkimadi, P. E., Kapaskelis, A., Rafailidis, P. I., & Falagas, M. E. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.151563 · Cited by 68
“Although current recommendations regarding most aspects of the treatment of this disease are evidence based, the issue of the appropriate duration of antibiotic treatment has not been subjected to adequate and conclusive research. As a consequence, relevant recommendations are primarily based on accumulated clinical e…”
BackgroundTubiana, S., Varon, E., Biron, C., Ploy, M.-C., Mourvillier, B., Taha, M., Revest, M., Poyart, C., Martin‐Blondel, G., Lecuit, M., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.12.020 · Cited by 77
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections
Joseph, J., & Rodvold, K. A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.4.561 · Cited by 80
“Higher doses of meropenem (2 g every 8 h) should be considered in these patients [131,132] .”
BackgroundDrug Insight: steroids in CNS infectious diseases—new indications for an old therapy
Fitch, M. T., & van de Beek, D. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0713 · Cited by 68
Frontera, J. A., Yang, D., Medicherla, C. B., Baskharoun, S., Bauman, K., Bell, L., Bhagat, D., Bondi, S., Chervinsky, A., Dygert, L., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200356 · Cited by 71
“Acute rehabilitation facility 11/107 (10) 13/124 (11) 1.”
Sensitivity of the Bacterial Meningitis Score in 889 Children with Bacterial Meningitis
Dubos, F., ROCQUE, F. D. L., Lévy, C., Bingen, É., Aujard, Y., Cohen, R., Bréart, G., Gendrel, D., & Chalumeau, M. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.07.012 · Cited by 74
The Use of Adjunctive Steroids in Central Nervous Infections
Gundamraj, S., & Hasbun, R. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.592017 · Cited by 71
Fleming, C., Russcher, H., Lindemans, J. W., & de Jonge, R. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1247 · Cited by 70
“In approximately 80% of the cases, culture results will reveal the causative agent; however, in patients receiving antibiotics prior to CSF analysis, results may be obscured, and the test sensitivity decreases by approximately 20% [3].”
BackgroundQuenot, J., Luyt, C. E., Roche, N., Chalumeau, M., Charles, P., Claessens, Y.-É., Lasocki, S., Bédos, J., Pean, Y., Philippart, F., et al. (2013) · Annals of Intensive Care · doi:10.1186/2110-5820-3-21 · Cited by 72
“, within the first 48–72 h [40].”
BONIS, P. D., Lofrese, G., Scoppettuolo, G., Spanu, T., Cultrera, R., Labonia, M., Cavallo, M. A., Mangiola, A., Anile, C., & Pompucci, A. (2015) · European Journal of Neurology · doi:10.1111/ene.12789 · Cited by 64
“Guidelines published by the Infectious Disease Society of America for the treatment of bacterial meningitis suggest that intraventricular dosage of colistin should be 10 mg daily and duration of therapy should be 21 days for infections caused by aerobic Gram-negative bacilli, although duration of treatment should be i…”
MethodPelegrín, I., Moragas, M., Suárez, C., Ribera, A., Verdaguer, R., Martínez‐Yélamos, S., Borrego, F. R., Ariza, J., Viladrich, P. F., & Cabellos, C. (2014) · Infection · doi:10.1007/s15010-014-0636-y · Cited by 68
“Thus, physicians should always consider adding ampicillin to cephalosporin when C-ABM is diagnosed in the emergency room without aetiological confirmation in patients above 50 years of age, as recommended in the IDSA guidelines [20].”
MethodCentral Nervous System Device Infections
Stenehjem, E. A., & Armstrong, W. S. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2011.09.006 · Cited by 62
Yakut, N., Soysal, A., Kepenekli, E., Dalgıç, N., Çiftdoğan, D. Y., Karaaslan, A., Akkoç, G., Demi̇r, S. Ö., Çağan, E., Celikboya, E., et al. (2018) · British Journal of Neurosurgery · doi:10.1080/02688697.2018.1467373 · Cited by 63
“pletely removed, in patients whose CSF fails to be sterilized with IV antibiotic therapy, or when therapeutic CSF concentrations cannot be achieved.(29) However, some studies recommend the”
BackgroundResultPerformance of a predictive rule to distinguish bacterial and viral meningitis
Chavanet, P., Schaller, C., Levy, C., Flores-Cordero, J. M., Arens, M. Q., Piroth, L., Bingen, É., & Portier, H. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.06.009 · Cited by 70
Antimicrobial-resistantStreptococcus pneumoniae: trends and management
Jacobs, M. R. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.619 · Cited by 62
Bacterial Infections of the Central Nervous System
Roos, K. L. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000242 · Cited by 64
Self-citationNeurological manifestations of COVID-19 – an approach to categories of pathology
Leven, Y., & Bösel, J. (2021) · Neurological Research and Practice · doi:10.1186/s42466-021-00138-9 · Cited by 69
Immunomodulatory Therapies in Neurologic Critical Care
McDaneld, L. M., Fields, J. D., BOURDETTE, D. N., & Bhardwaj, A. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9274-0 · Cited by 66
“The current Infectious Diseases Society of America advocate dexamethasone 0.15 mg/kg IV q 6 h for 2–4 days for all adults with suspected bacterial meningitis given at the time of, or just prior to, the initiation of antibiotic therapy [ 116 ].”
MethodInfluentialBacterial infections other than spontaneous bacterial peritonitis in cirrhosis
Bunchorntavakul, C., & Chavalitdhamrong, D. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i5.158 · Cited by 64
Central Nervous System Syndromes in Solid Organ Transplant Recipients
Wright, A. J., & Fishman, J. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu428 · Cited by 62
Colistin: Re-emergence of the ′forgotten′ antimicrobial agent
Dhariwal, A., & Tullu, M. S. (2013) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.118040 · Cited by 71
Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides
Chen, L. F., & Kaye, D. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.06.004 · Cited by 75
Lévy, C., Varon, E., Pïcard, C., Béchet, S., Martinot, A., Bonacorsi, S., & Cohen, R. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000451 · Cited by 60
“However, the serotype replacement particularly with serotype 19a, which showed distinct patterns of beta-lactam resistance, with moderate or high-level resistance to third-generation cephalosporins, did not lead to modifying the guidelines.(35,36) indeed, in our study, 88.”
BackgroundFotakopoulos, G., Makris, D. A., Chatzi, M., Tsimitrea, E., Zakynthinos, E. G., & Fountas, K. N. (2016) · Acta Neurochirurgica · doi:10.1007/s00701-016-2702-y · Cited by 61
“The Infectious Diseases Society of America (IDSA) in 2004 proposed a daily dosage of colistin administered via the intrathecal/intraventricular (ITH/IVT) route, equal to 10 mg (125,000 IU) [36], but in practice there is a wide range from 1.”
BackgroundDexamethasone in Adults with Community-Acquired Bacterial Meningitis
van de Beek, D., & de Gans, J. (2006) · Drugs · doi:10.2165/00003495-200666040-00002 · Cited by 65
Hoen, B., Varon, E., Debroucker, T., Fantin, B., Grimprel, E., Wolff, M., & Duval, X. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.03.009 · Cited by 67
Antibiotic Allergies in the Medical Record: Effect on Drug Selection and Assessment of Validity
Lutomski, D. M., LaFollette, J. A., Biaglow, M. A., & Haglund, L. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.11.1348 · Cited by 67
Harcourt, B. H., Anderson, R. D., Wu, H. M., Cohn, A. C., MacNeil, J. R., Taylor, T. H., Wang, X., Clark, T. A., Messonnier, N. E., & Mayer, L. W. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv117 · Cited by 60
“[2], it may be used as the definitive treatment when meningococcal disease is confirmed [3, 28].”
BackgroundCommunity-acquired Bacterial Meningitis in Adults With Cerebrospinal Fluid Leakage
ter Horst, L., Brouwer, M. C., ENDE, A. V. D., & van de Beek, D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz649 · Cited by 62
“Bacterial meningitis in patients with CSF leakage can be classified as community acquired, in case of anatomic defects or contiguous spread of infection, or nosocomial or healthcare-associated meningitis after surgery for trauma [5, 7, 8].”
BackgroundDiagnosis and Management of Bacterial Meningitis in the Paediatric Population: A Review
Tacon, C. L., & Flower, O. J. (2012) · Emergency Medicine International · doi:10.1155/2012/320309 · Cited by 73
“Although it may remain positive for up to 10 days after the initiation of antibiotics [19], it is neither 100% sensitive or specific [9, 19].”
BackgroundInfluentialWillems, E., Smismans, A., Cartuyvels, R., Coppens, G., Vaerenbergh, K. V., den Abeele, A. V., & Frans, J. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.01.009 · Cited by 63
“According to existing guidelines, it is mandatory to obtain blood cultures in sepsis, meningitis, catheter-related bacteremia, infectious endocarditis, arthritis, osteomyelitis, and fever of unknown origin (Baron et al., 2005; CLSI, 2007; Cohen et al., 2004; Dellinger et al., 2008; Isenberg, 2010; Mandell et al., 2010…”
Mago, V., Mehta, R., Woolrych, R., & Papageorgiou, E. I. (2012) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-12-98 · Cited by 63
“At a macro level, a number of studies have shown that the diagnosis and treatment management of meningitis is a complex and challenging problem for government and healthcare agencies requiring novel approaches to its management and intervention [11-14].”
BackgroundMuthucumarana, K., Howson, P., Crawford, D., Burrows, S., Swaminathan, R., & Irish, A. B. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.05.003 · Cited by 64
Dashti, A. S., Alizadeh, S., Karimi, A., Khalifeh, M., & Shoja, S. A. (2017) · Medicine · doi:10.1097/md.0000000000007637 · Cited by 76
“As is emphasized in other studies, due to the critical nature of bacterial meningitis, using a biomarker alone is not recommended to establish or exclude the diagnosis.([5,15,60]) We combined 4 biomarkers (CRP, ESR, CSFlactate, and CSF-ANC) together to find the best compositions.”
BackgroundNeonatal sepsis: within and beyond China
Dong, Y., Basmaci, R., Titomanlio, L., Sun, B., & Mercier, J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000935 · Cited by 65
“A fruitful dialogue should be maintained between neonatologists and microbiologists to optimize the duration of antibiotic treatment, which relies often upon empirical rules: 7 to 10 days for bacteremia, 14 days for Gram-positive meningitis, and 21 days for Gram-negative meningitis,([3,68]) Given the general trend to…”
BackgroundInfectious Disease Complications in Patients with Cancer
Seo, S. K., Liu, C., & Dadwal, S. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2020.09.001 · Cited by 68
A hospital-based study on etiology and prognosis of bacterial meningitis in adults
Sunwoo, J., Shin, H., Lee, H. S., Moon, J., Lee, S., Jung, K., Park, K., Jung, K., Kim, M., Lee, S. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85382-4 · Cited by 72
Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation
Bingen, É., Lévy, C., Varon, E., ROCQUE, F. D. L., BOUCHERAT, M., d’Athis, P., Aujard, Y., Cohen, R., & The Bacterial Meningitis Study Group (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0417-y · Cited by 56
“7%) supports the use of vancomycin in addition to high dosage of a thirdgeneration cephalosporin, as recommended by American guidelines since 1996 [3, 6, 7].”
Treatment of Meningococcal Disease
Nadel, S. (2016) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.04.013 · Cited by 79
“15 mg/kg 4 times per day for 2e4 days is recommended [14,25].”
BackgroundXu, M., Hu, L., Huang, H., Wang, L., Tan, J., Zhang, Y., Chen, C., Zhang, X., & Huang, L. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00031 · Cited by 72
DeRyke, C. A., & Alexander, D. P. (2009) · Hospital Pharmacy · doi:10.1310/hpj4409-751 · Cited by 63
“In response to these factors, a shift in the defined target trough concentrations of vancomycin from 5 to 10 mcg/mL to 15 to 20 mcg/mL has been recommended in contemporary treatment guidelines for nosocomial pneumonia and meningitis.(14,15) However, there are no published clinical data demonstrating that troughs of 15…”
BackgroundChanging Epidemiology of Adult Bacterial Meningitis in Southern Taiwan: A Hospital-Based Study
Chang, W., Lu, C., Huang, C., Tsai, N., Chuang, Y.-C., Chang, C.-W., Chen, S.-F., & Chien, C. (2008) · Infection · doi:10.1007/s15010-007-7009-8 · Cited by 57
“Because early appropriate antibiotic therapy is one of the important and explicit steps in the management of potentially fatal central nervous system (CNS) infection, these recent epidemiologic trends have influenced the choice of initial empiric antibiotic treatment [17, 18].”
BackgroundEmergency management of meningococcal disease: eight years on
Pollard, A. J., Nadel, S., Ninis, N., Faust, S. N., & Levin, M. (2007) · Archives of Disease in Childhood · doi:10.1136/adc.2006.102384 · Cited by 58
“Although the approach that we have used is generally in keeping with the standard approach to the sick child, there are two areas of particular controversy: whether to undertake a lumbar puncture (LP); and the use of adjunctive steroids. We advise a cautious approach to lumbar puncture in children with meningococcal d…”
MethodInvasive meningococcal disease
Strelow, V. L., & Vidal, J. E. (2013) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20130144 · Cited by 59
Antimicrobial Therapy for Life-threatening Infections: Speed is Life
Funk, D. J., & Kumar, A. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2010.09.008 · Cited by 70
Emergency Department Management of Meningitis and Encephalitis
Fitch, M. T., Abrahamian, F. M., Moran, G. J., & Talan, D. A. (2008) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.10.001 · Cited by 68
“Bacterial meningitis is a life-threatening infection, and empiric administration of broad-spectrum antibiotics (Table 1) is indicated for patients suffering from this disease until bacterial identification is made [1,5,62,78,91].”
BackgroundMethodInfluentialInfectious Meningitis and Encephalitis
Bystritsky, R. J., & Chow, F. C. (2021) · Neurologic Clinics · doi:10.1016/j.ncl.2021.08.006 · Cited by 64
Candel, F. J., Salavert, M., Cantón, R., del Pozo, J. L., Galán‐Sánchez, F., Navarro, D., Rodríguez, A. H., Rodríguez, J. C., Rodríguez-Aguirregabiria, M., Suberviola, B., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05224-3 · Cited by 84
“Some viruses, such as enterovirus and herpesvirus, exhibited lower sensitivity [162, 164, 165, 167].”
Diagnosis, initial management, and prevention of meningitis.
Bamberger, D. M. (2010) · PubMed · Cited by 75
Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid
Paolo, A. D., Gori, G., Tascini, C., Danesi, R., & Tacca, M. D. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0062-9 · Cited by 57
“[115].”
BackgroundBacterial Meningitis: Epidemiology, Pathogenesis and Management Update
Nudelman, Y., & Tunkel, A. R. (2009) · Drugs · doi:10.2165/11530590-000000000-00000 · Cited by 75
Self-citationRapid diagnostic tests for neurological infections in central Africa
Yansouni, C. P., Bottieau, E., Lutumba, P. T., Winkler, A. S., Lynen, L., Büscher, P., Jacobs, J. A., Gillet, P., Lejon, V., Alirol, E., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70004-5 · Cited by 57
Brandileone, M. C. C., Casagrande, S. T., Guerra, M.-L. L. S., Zanella, R. C., de Andrade, A.-L. S. S., & Fábio, J. L. D. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46387-0 · Cited by 55
“In fact, the most serious effect of penicillin resistance in pneumococci is encountered in meningitis due to the poor penetration of the antibiotic into the cerebrospinal fluid, so that it is difficult to achieve the required bactericidal concentration (Bashir et al., 2003; Tunkel et al., 2004).”
BackgroundLee, S. H., Chen, S.-Y., Chien, J.-Y., Lee, T.-F., Chen, J.-M., & Hsueh, P.-R. (2019) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2019.04.005 · Cited by 54
Comparative review of imipenem/cilastatin versus meropenem
Salmon‐Rousseau, A., Martins, C., Blot, M., Buisson, M., Mahy, S., Chavanet, P., & Piroth, L. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2020.01.001 · Cited by 54
Adult Klebsiella pneumoniae meningitis in Taiwan: an overview.
Chang, W., Huang, C.-R., Lu, C., & Chien, C. (2012) · PubMed · Cited by 56
Salazar, L., & Hasbun, R. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix240 · Cited by 58
Rapid diagnosis of bacterial meningitis by nanopore 16S amplicon sequencing: A pilot study
Moon, J., Kim, N., Kim, T., Jun, J., Lee, H. S., Shin, H., Lee, S., Jung, K., Park, K., Jung, K., et al. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.151338 · Cited by 68
Spanu, T., Romano, L., D'Inzeo, T., Masucci, L., Albanese, A., Papacci, F., Marchese, E., Sanguinetti, M., & Fadda, G. (2005) · Clinical Infectious Diseases · doi:10.1086/432577 · Cited by 53
Evaluation of a Potential Clinical Interaction between Ceftriaxone and Calcium
Steadman, E. J., Raisch, D. W., Bennett, C. L., Esterly, J. S., Becker, T., Postelnick, M. J., McKoy, J. M., Trifilio, S. M., Yarnold, P. R., & Scheetz, M. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01111-09 · Cited by 55
Infectious disease emergencies
Shah, K. H., Lee, J., Medlej, K., & Weingart, S. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139523936.054 · Cited by 53
Comparison of culture and PCR methods in the diagnosis of bacterial meningitis
Başpınar, E. Ö., Dayan, S., Bekçibaşı, M., Tekin, R., Ayaz, C., Deveci, Ö., & Hoşoğlu, S. (2017) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2016.06.014 · Cited by 53
The Use of Carbapenems in the Treatment of Serious Infections
Baughman, R. P. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609335660 · Cited by 62
“These include complicated skin and soft tissue infections,(82) septicemia,(83) and meningitis.(84) Carbapenems have also been widely used in the treatment of P aeruginosa and other gram-negative rod infections in patients with cystic fibrosis because of superior susceptibility rates against pathogens commonly found in…”
BackgroundDiagnosis of reversible causes of coma
Thill, C., Huynh-Moynot, S., & Giacardi, C. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60629-8 · Cited by 52
Patient and Organizational Factors Associated With Delays in Antimicrobial Therapy for Septic Shock*
Amaral, A. C. K. B., Fowler, R. A., Pinto, R., Rubenfeld, G. D., Ellis, P., Bookatz, B., Marshall, J. C., Martinka, G., Keenan, S., Laporta, D., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001868 · Cited by 51
“Application of this approach to presumed bacterial meningitis was highly successful and now represents the standard of practice (31, 32).”
BackgroundKaraiskos, I., Galani, L., Baziaka, F., Katsouda, E., Ioannidis, I., Andreou, A., Paskalis, H., & Giamarellou, H. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.02.010 · Cited by 52
Tseng, Y., Kao, Y.-C., Liao, J.-Y., Chen, W.-A., & Liu, S. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400108q · Cited by 52
Moon, S., Chung, D. R., Kim, S., Chang, H., Lee, H., Jung, D. S., Ys, K., Jung, S., Ryu, S. Y., Heo, S. T., et al. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0929-8 · Cited by 52
“immunity, diabetes, alcoholism, chronic renal failure, collagen vascular disease, and diseases related to iron overload or decreased gastric acidity [3, 28, 29].”
BackgroundTat-functionalized liposomes for the treatment of meningitis: an in vitro study
Garcia, C. B., Shi, D., & Webster, T. J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s130125 · Cited by 57
“aureus (MRSA), which can also cause meningitis, depending on the age of the person and if that person has suffered any head trauma.(14) Escherichia coli was also tested.”
Guo, Y., Zeng, H., & Chen, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9931742 · Cited by 59
“When the CNS suffers from bacterial infection, numerous neutrophils infiltrate the brain parenchyma and cerebrospinal fluid to resist the invasion of bacteria [1].”
BackgroundFranco-Paredes, C., Lammoglia, L., Hernández, I., & Santos-Preciado, J. I. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2007.09.012 · Cited by 51
Surgical Site Infections Following Bariatric Surgery in Community Hospitals: A Weighty Concern?
Freeman, J. T., Anderson, D. J., Hartwig, M. G., & Sexton, D. J. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0105-3 · Cited by 51
The Causes and Treatment Outcomes of 91 Patients with Adult Nosocomial Meningitis
Kim, H.-I., Kim, S., Park, G., Kwon, E., Kim, H.-H., Jeong, J.-Y., Chang, H., Lee, J., & Kim, N.-S. (2012) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2012.27.2.171 · Cited by 53
Li, J., Udy, A. A., Kirkpatrick, C. M. J., Lipman, J., & Roberts, J. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.08.017 · Cited by 51
Akhuemokhan, O. C., Ewah-Odiase, R. O., Akpede, N., Ehimuan, J., Adomeh, D. I., Odia, I., Olomu, S. C., Pahlmann, M., Becker‐Ziaja, B., Happi, C. T., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005711 · Cited by 50
“However, the diagnosis of possible bacterial meningitis was not based only on this parameter but on both total and differential white blood cell count and the presence of typical biochemical changes [42,44,45], which are known to have a high sensitivity and specificity for bacterial meningitis [44,45].”
BackgroundDisaster Preparedness: Biological Threats and Treatment Options
Narayanan, N., Lacy, C. R., Cruz, J. E., Nahass, M. M., Karp, J., Barone, J. A., & DeSantis, E. R. H. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2068 · Cited by 53
Costerus, J. M., Brouwer, M. C., Sprengers, M. E. S., Roosendaal, S. D., van der Ende, A., & van de Beek, D. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy200 · Cited by 49
Mortality indicators in pneumococcal meningitis: therapeutic implications
Erdem, H., Elaldi, N., Öztoprak, N., Sengoz, G., Ak, O., Kaya, S., Inan, A., Nayman-Alpat, S., Ulu-Kilic, A., Pekok, A. U., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.09.012 · Cited by 49
“Adding rifampin to other antibiotics in the management of pneumococcal meningitis is another option in cases where vancomycin has the potential to fail.(7) Further studies are also needed on daptomycin and newer glycopeptides to determine their place in the management of pneumococcal meningitis.”
BackgroundLeonard, S. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042103 · Cited by 53
“[12,13,14,15] The clinical use of combination therapy for MRSA, outside of the clinical practice guidelines above, has become ubiquitous and thus there is an ongoing need to characterize antimicrobial interactions to find the most potentially useful combinations.”
BackgroundDiagnostic approaches for patients with suspected encephalitis
Bloch, K. C., & Glaser, C. A. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-0049-5 · Cited by 53
“Patients with underlying immunocompromise, recent seizures, or focal neurologic signs, including altered mentation or papilledema, should have either a noncontrast CT scan or MRI scan performed prior to lumbar puncture [ 4 ].”
BackgroundBlumenthal, K. G., Youngster, I., Rabideau, D. J., Parker, R. A., Manning, K. S., Walensky, R. P., & Nelson, S. B. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.005 · Cited by 55
Glimåker, M., Sjölin, J., Åkesson, S., & Nauclér, P. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix806 · Cited by 51
“It has been stated that LP may cause fatal herniation in cases with brain abscess, although the potential risk has been estimated to be small, about 1% [7, 24].”
BackgroundBrouwer, M. C., & van de Beek, D. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101922 · Cited by 57
Nailor, M. D., & Sobel, J. D. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.06.010 · Cited by 54
Bargiacchi, O., Rossati, A., Car, P., Brustia, D., Brondolo, R., Rosa, F. G. D., Garavelli, P. L., & Rosa, F. G. D. (2014) · Infection · doi:10.1007/s15010-014-0618-0 · Cited by 48
“colistin administered via the ITH route should be equal to 10 mg (125,000 IU) [51].”
BackgroundPrevention of bacterial meningitis: An overview of Cochrane systematic reviews
Prasad, K., & Karlupia, N. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.06.030 · Cited by 48
Early lumbar puncture in adult bacterial meningitis—rationale for revised guidelines
Glimåker, M., Johansson, B., Bell, M., Ericsson, M., Bläckberg, J., Brink, M., Lindquist, L., & Sjölin, J. (2013) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2013.799289 · Cited by 51
“Bacterial brain abscess, the cerebral mass lesion that may be particularly diffi cult to clinically distinguish from ABM, has been estimated to be associated with an incidence of LP-induced herniation of about 1 – 2% [23,45].”
BackgroundInfluentialCeftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report
Holyk, A., Belden, V., Lee, J. J., Musick, W. L., Keul, R., Britz, G. W., & Lin, J. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx358 · Cited by 48
Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19
Valdes, E., Fuchs, B., Morrison, C., Charvet, L. E., Lewis, A., Thawani, S., Balcer, L. J., Galetta, S. L., Wısnıewskı, T., & Frontera, J. A. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120146 · Cited by 53
Douglas, V. C., & Josephson, S. A. (2011) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000407055.17661.33 · Cited by 50
“A head CT is also recommended prior to performing a lumbar puncture.(14) Other situations in TABLE 1-3 DeliriumRisk Factors and Iatrogenic Precipitants”
Clinical Characteristics of Infections in Humans Due to Staphylococcus epidermidis
Rupp, M. E. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-736-5_1 · Cited by 57
Avolio, M., Diamante, P., Zamparo, S., Modolo, M. L., Grosso, S., Zigante, P., Tosoni, N., Rosa, R. D., Stano, P., & Camporese, A. (2010) · Shock · doi:10.1097/shk.0b013e3181d49299 · Cited by 53
Harz, M., Kiehntopf, M., Stöckel, S., Rösch, P., Deufel, T., & Popp, J. (2008) · The Analyst · doi:10.1039/b716132h · Cited by 47
Moussa, W. M. M., & Mohamed, M. A. A. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.02.034 · Cited by 47
Lu, C. J., Zhang, Y., Chen, M., Zhong, P., Chen, Y., Yu, J., Wu, X., Wu, J., & Zhang, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00997-16 · Cited by 47
“It was recommended by the guidelines of both the Infectious Diseases Society of America in 2004 and the European Federation of Neurological Societies in 2008 (which are still effective) as one of the empirical treatments for bacterial meningitis (9, 10).”
Method
Metadata
- Authors
- Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J.
- Affiliations
- Drexel University (US)
- Weill Cornell Medical Center (US)
- Baylor College of Medicine (US)
- Medical College of Wisconsin (US)
- Indiana University School of Medicine (US)
- University of Virginia (US)
- University of Alabama at Birmingham (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-01
- Volume
- 39
- Issue
- 9
- Pages
- 1267-1284
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2143206150
- Cited by
- 2,308
- References
- 137
- Citations by year
- 2026: 111 · 2025: 99 · 2024: 101 · 2023: 83 · 2022: 115 · 2021: 131 · 2020: 125 · 2019: 128 · 2018: 116 · 2017: 142 · 2016: 121 · 2015: 142 · 2014: 102 · 2013: 128 · 2012: 117
- FWCI
- 44.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- bacterial meningitis, diagnosis, management, antimicrobial therapy, clinical guidelines
- MeSH terms
- Adult, Algorithms, Anti-Bacterial Agents, Cerebrospinal Fluid Shunts, Child, Humans, Infant, Infant, Newborn, Meningitis, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.